Coordinatore | DEUTSCHES PRIMATENZENTRUM GMBH
Organization address
address: KELLNERWEG 4 contact info |
Nazionalità Coordinatore | Germany [DE] |
Totale costo | 9˙237˙084 € |
EC contributo | 6˙999˙999 € |
Programma | FP7-INFRASTRUCTURES
Specific Programme "Capacities": Research infrastructures |
Code Call | FP7-INFRASTRUCTURES-2010-1 |
Funding Scheme | CP-CSA-Infra |
Anno di inizio | 2011 |
Periodo (anno-mese-giorno) | 2011-01-01 - 2015-06-30 |
# | ||||
---|---|---|---|---|
1 |
DEUTSCHES PRIMATENZENTRUM GMBH
Organization address
address: KELLNERWEG 4 contact info |
DE (GOTTINGEN) | coordinator | 2˙698˙438.80 |
2 |
STICHTING BIOMEDICAL PRIMATE RESEARCH CENTER
Organization address
address: LANGE KLEIWEG 161 contact info |
NL (RIJSWIJK ZH) | participant | 2˙697˙430.50 |
3 |
Department of Health
Organization address
address: Quarry House, Quarry Hill contact info |
UK (Leeds) | participant | 634˙748.75 |
4 |
KAROLINSKA INSTITUTET
Organization address
address: Nobels Vag 5 contact info |
SE (STOCKHOLM) | participant | 344˙355.00 |
5 |
CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE
Organization address
address: Rue Michel -Ange 3 contact info |
FR (PARIS) | participant | 252˙520.00 |
6 |
SMITTSKYDDSINSTITUTET
Organization address
address: Nobels vaeg 18 contact info |
SE (SOLNA) | participant | 120˙675.00 |
7 |
UNIVERSITE DE STRASBOURG
Organization address
address: rue Blaise Pascal 4 contact info |
FR (Strasbourg) | participant | 96˙300.00 |
8 |
CONSIGLIO NAZIONALE DELLE RICERCHE
Organization address
address: Piazzale Aldo Moro 7 contact info |
IT (ROMA) | participant | 78˙110.00 |
9 |
WESTFAELISCHE WILHELMS-UNIVERSITAET MUENSTER
Organization address
address: SCHLOSSPLATZ 2 contact info |
DE (MUENSTER) | participant | 43˙181.56 |
10 |
MEDICAL RESEARCH COUNCIL
Organization address
address: NORTH STAR AVENUE POLARIS HOUSE contact info |
UK (SWINDON) | participant | 34˙240.00 |
11 |
HEALTH PROTECTION AGENCY HPA
Organization address
address: Central Office - 7th Floor, Holborn Gate - High Holborn 330 contact info |
UK (LONDON) | participant | 0.00 |
Esplora la "nuvola delle parole (Word Cloud) per avere un'idea di massima del progetto.
'Biomedical research depends on the availability of living non-human primates and biological material with primate origin. The need for animal research using non-human primates is therefore recognised by all governments that support internationally competitive biomedical research aimed at addressing the world’s most pressing medical challenges. While essential for biomedical research owing to their similarity to humans, non-human primates are more than other animals endowed with high sensory and cognitive abilities. This is the basis of an international consensus that the use of primates in research has to comply with the highest ethical standards and should be restricted to cases where no alternatives exist. Research with primates has to follow the 3R-concept of Refinement, Reduction and Replacement. Meeting this requirement necessitates a commitment to substantial investments into appropriate facilities, specialized equipment and extensive training of personnel, which has been realised by the establishment of the I3-project EUPRIM-Net in the 6th framework programme. The aim of EUPRIM-Net is to contribute to European science by improving the ability of its participants to provide the best services, support the best science that meets the highest ethical standards for primate-based animal research. With the funding of EUPRIM-Net II we will build on the successes of the starting phase of EUPRIM-Net to focus on the following overarching core objectives:
- advancing the 3Rs (refinement, reduction, replacement) in primate research
- develop, refine and ensure best practice in primate research
- extend the network in Europe to include commercial partners and extend the network to include non-European primate centres to insure a global sharing of available resources.
Additionally, EUPRIM-Net places a focus on moving away from EU funding and implementing self-sustaining structures.'
Non-human primates (NHPs) are essential for biomedical research. However, they are endowed with a high level of sensory and cognitive abilities and their use in the laboratory must comply with the highest ethical standards.
European clinical research infrastructures network for clinical trials and biotherapy - preparatory phase for the infrastructure
Read More